MSF welcomes GSK's decision to lower the price of the pneumonia vaccine for some of the world's most vulnerable children.
On September 20th, 2016 Médecins Sans Frontiéres/Doctors without Borders (MSF) welcomed the decision by GlaxoSmithKline (GSK) to lower its price of its pneumococcal conjugate vaccine (PCV) for humanitarian organizations that serve refugee and crisis-affected children.
Read on for the entire announcement here.
Nov 15, 2024
“A group of governments, multilateral development banks, UN agencies, and some of the world’s largest philanthropic organizations are announcing expanded efforts and increased coordination and... Read more
Nov 12, 2024
“The right funding now can protect the frontlines of the climate crisis from the worst effects of extreme weather events. For many developing countries, particularly in Africa, the cost of... Read more
Oct 15, 2024
“Everyone should have access to enough, nutritious, diverse, affordable, and safe foods.” -- FAO October 16 is marked each year as World Food Day. This year the UN invites us to focus on foods... Read more